Curcumin and Quercetin in Colon Cancer: Role of Macrophage-Induced Inflammation

姜黄素和槲皮素在结肠癌中:巨噬细胞诱导的炎症的作用

基本信息

项目摘要

DESCRIPTION (provided by applicant): Colorectal cancer (CRC) is the second leading cause of cancer death in the United States and the fourth most commonly diagnosed cancer. There is increasing recognition of diet-induced modulation of inflammatory responses as being central to the processes of human carcinogenesis. The argument for this stems from the observations that pro-inflammatory states are closely linked to tumor promotion. The consumption of the anti- inflammatory dietary constituents curcumin, which is a component of the Indian spice currie, and quercetin, a flavonoid present in various fruits and vegetables, have been associated with reduced CRC risk. Such components of diet are generally known to have a much wider safety margin with chronic use than are anti- inflammatory drugs, which make them more viable candidates to aid in cancer prevention. While a number of studies have examined the effects of dietary supplements on inflammation in cancer, none have specifically examined the role of tissue macrophages (Ms), primary mediators of inflammation, on these effects. Further, few have examined combinations of dietary supplements on the biological mechanisms of carcinogenesis. The overarching goal of this proposed project is to 1) determine the independent and combined effects of the anti-inflammatory dietary constituents curcumin and quercetin on CRC progression, and 2) to determine whether these benefits result from a reduction in M-induced inflammation. It is clear that M-induced inflammation plays an important part in the initiation and progression of CRC, and it may also be responsible for various sickness behaviors like fatigue, lack of appetite, and body wasting that can drastically decrease quality of life in CRC patients. A substantial proportion and perhaps the majority of CRCs are associated with non-genetic factors, such as inadequate and/or over nutrition, which can amplify inflammation in a number of ways. An independent, additive or synergistic effect of the anti-inflammatory dietary constituents curcumin and quercetin may be of critical public health significance in the prevention of CRC. The specific aims of this project are to 1) to elucidate the combined effects of curcumin and quercetin on M infiltration, inflammation, CRC progression and host survival and 2) to more specifically determine the role of M-induced inflammation on these effects. A mouse transgenic model of CRC will be used to determine the independent and combined effects of curcumin and quercetin on inflammatory processes, M infiltration, tumor progression and host survival at specific stages of CRC (e.g. prevention versus treatment). Furthermore, we will use M manipulation techniques to evaluate whether Ms are an important common pathway of the effects of curcumin and quercetin on inflammation, tumor progression and host survival. The overall goal of this project is to develop a clinically testable regimen to delay and/or prevent CRC and to begin to understand if the mechanisms of the effects are related to M infiltration and subsequent inflammation that could be targeted by further behavioral and or medical treatment. PUBLIC HEALTH RELEVANCE: The dietary compounds curcumin, a component of the Indian spice curry, and quercetin, a component of some fruits and vegetables, have anti-inflammatory properties and have been associated with reduced colon cancer risk. These compounds modify inflammatory processes which may be linked with the formation and development of tumors. The goal of the proposed study is to investigate the independent and combined effects of curcumin and quercetin on the progression of colon cancer and to determine if these effects result from a reduction in macrophage-induced inflammation.
描述(由申请人提供):结直肠癌(CRC)是美国癌症死亡的第二大原因,也是第四个常见的癌症。越来越多地认识到饮食引起的炎症反应的调节是人类癌变过程的核心。这一论点源于观察到促炎状态与肿瘤促进密切相关的观察结果。抗炎饮食成分姜黄素的消耗是印度香料咖喱的组成部分,以及在各种水果和蔬菜中存在的类黄酮的槲皮素与CRC风险降低有关。众所周知,这种饮食的这种组成部分具有长期使用的安全性比抗炎性药物更大,这使得它们更可行,以帮助预防癌症。尽管许多研究检查了饮食补充剂对癌症炎症的影响,但没有一项专门研究组织巨噬细胞(MS),炎症的主要介体对这些影响的作用。此外,很少有人检查了饮食补充剂的结合,以癌变的生物学机制。该提出的项目的总体目标是1)确定抗炎饮食成分姜黄素和槲皮素对CRC进展的独立和综合作用,以及2)确定这些益处是否是由于M诱发的炎症的减少而导致的。显然,M诱导的炎症在CRC的启动和进展中起着重要的作用,并且可能导致各种疾病行为,例如疲劳,缺乏食欲和身体浪费,可以大大降低CRC患者的生活质量。很大的比例,也许大多数CRC都与非遗传因素有关,例如不充分和/或过度营养,这可以通过多种方式扩增炎症。抗炎饮食成分姜黄素和槲皮素的独立,加性或协同作用在预防CRC中可能具有至关重要的公共健康意义。该项目的具体目的是1)阐明姜黄素和槲皮素对M浸润,炎症,CRC进展和宿主存活的综合作用以及2)更具体地确定M诱导的炎症对这些作用的作用。 CRC的小鼠转基因模型将用于确定姜黄素和槲皮素对CRC特定阶段的炎症过程,M浸润,肿瘤进展以及宿主存活的独立和综合作用(例如预防与治疗)。此外,我们将使用M操纵技术来评估MS是否是姜黄素和槲皮素对炎症,肿瘤进展和宿主存活的影响的重要常见途径。该项目的总体目标是开发可延迟和/或预防CRC的临床测试方案,并开始了解该作用的机制是否与M浸润以及随后的炎症有关,这可能是通过进一步的行为和/或医疗来针对的。公共卫生相关性:饮食化合物姜黄素是印度香料咖喱的组成部分,槲皮素是一些水果和蔬菜的组成部分,具有抗炎特性,并且与结肠癌风险降低有关。这些化合物改变了可能与肿瘤的形成和发育有关的炎症过程。拟议的研究的目的是研究姜黄素和槲皮素对结肠癌进展的独立和综合作用,并确定这些作用是否导致巨噬细胞诱发的炎症的减少导致。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ELIZABETH ANGELA MURPHY其他文献

ELIZABETH ANGELA MURPHY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ELIZABETH ANGELA MURPHY', 18)}}的其他基金

Harnessing the Power of p53 with Panaxynol from American Ginseng to Suppress Colitis and Prevent Colon Cancer - admin supp
利用 p53 与西洋参中的人参醇的功效来抑制结肠炎和预防结肠癌 - admin support
  • 批准号:
    10380268
  • 财政年份:
    2021
  • 资助金额:
    $ 19.01万
  • 项目类别:
Emodin as a chemopreventive agent for breast cancer - admin supp
大黄素作为乳腺癌的化学预防剂 - 行政支持
  • 批准号:
    10027034
  • 财政年份:
    2018
  • 资助金额:
    $ 19.01万
  • 项目类别:
Linking macrophages to gut microbiota in obesity-enhanced colon cancer
将巨噬细胞与肥胖增强的结肠癌中的肠道微生物群联系起来
  • 批准号:
    9024980
  • 财政年份:
    2016
  • 资助金额:
    $ 19.01万
  • 项目类别:
Regulation of Macrophages by miRNA-155 in Colon Cancer: Benefits of Quercetin
结肠癌中 miRNA-155 调节巨噬细胞:槲皮素的益处
  • 批准号:
    8637442
  • 财政年份:
    2014
  • 资助金额:
    $ 19.01万
  • 项目类别:
Regulation of Macrophages in Obesity-Enhanced Colon Cancer:Benefits of Quercetin
肥胖加剧的结肠癌中巨噬细胞的调节:槲皮素的好处
  • 批准号:
    8651431
  • 财政年份:
    2013
  • 资助金额:
    $ 19.01万
  • 项目类别:
Regulation of Macrophages in Obesity-Enhanced Colon Cancer:Benefits of Quercetin
肥胖加剧的结肠癌中巨噬细胞的调节:槲皮素的好处
  • 批准号:
    8487738
  • 财政年份:
    2013
  • 资助金额:
    $ 19.01万
  • 项目类别:
Macrophages in High Fat Diet Enhanced Colorectal Cancer: Regulation by miRNA-155
高脂肪饮食中的巨噬细胞增强结直肠癌:miRNA-155 的调节
  • 批准号:
    8512253
  • 财政年份:
    2013
  • 资助金额:
    $ 19.01万
  • 项目类别:
Macrophages in High Fat Diet Enhanced Colorectal Cancer: Regulation by miRNA-155
高脂肪饮食中的巨噬细胞增强结直肠癌:miRNA-155 的调节
  • 批准号:
    8631075
  • 财政年份:
    2013
  • 资助金额:
    $ 19.01万
  • 项目类别:
Regulation of Macrophages in Obesity-Enhanced Colon Cancer:Benefits of Quercetin
肥胖加剧的结肠癌中巨噬细胞的调节:槲皮素的好处
  • 批准号:
    9052723
  • 财政年份:
    2013
  • 资助金额:
    $ 19.01万
  • 项目类别:
Macrophage-lnduced Inflammation in High Fat Diet Enhanced Breast Cancer (Proj 4)
高脂肪饮食中巨噬细胞诱导的炎症会加剧乳腺癌(项目 4)
  • 批准号:
    8531300
  • 财政年份:
  • 资助金额:
    $ 19.01万
  • 项目类别:

相似国自然基金

时空序列驱动的神经形态视觉目标识别算法研究
  • 批准号:
    61906126
  • 批准年份:
    2019
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
  • 批准号:
    41901325
  • 批准年份:
    2019
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
  • 批准号:
    61802133
  • 批准年份:
    2018
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
  • 批准号:
    61872252
  • 批准年份:
    2018
  • 资助金额:
    64.0 万元
  • 项目类别:
    面上项目
针对内存攻击对象的内存安全防御技术研究
  • 批准号:
    61802432
  • 批准年份:
    2018
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

A suite of conditional mouse models for secretome labeling
一套用于分泌蛋白组标记的条件小鼠模型
  • 批准号:
    10640784
  • 财政年份:
    2023
  • 资助金额:
    $ 19.01万
  • 项目类别:
Structurally engineered furan fatty acids for the treatment of dyslipidemia and cardiovascular disease
结构工程呋喃脂肪酸用于治疗血脂异常和心血管疾病
  • 批准号:
    10603408
  • 财政年份:
    2023
  • 资助金额:
    $ 19.01万
  • 项目类别:
Molecular Mechanisms of TRIB1 Regulation of Hepatic Metabolism
TRIB1调节肝脏代谢的分子机制
  • 批准号:
    10660520
  • 财政年份:
    2023
  • 资助金额:
    $ 19.01万
  • 项目类别:
Characterizing the role of LDL related receptor 1 (Lrp1) as host entry factor for multiple bunyaviruses
描述 LDL 相关受体 1 (Lrp1) 作为多种布尼亚病毒宿主进入因子的作用
  • 批准号:
    10667857
  • 财政年份:
    2023
  • 资助金额:
    $ 19.01万
  • 项目类别:
Neuroimmune interactions for laryngeal sensorimotor neuropathy in postviral influenza infection
病毒性流感感染后喉部感觉运动神经病变的神经免疫相互作用
  • 批准号:
    10827254
  • 财政年份:
    2023
  • 资助金额:
    $ 19.01万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了